CRIS Current Research Information System

AVONI, PATRIZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.259
EU - Europa 2.842
AS - Asia 1.406
AF - Africa 168
SA - Sud America 7
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.688
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.247
GB - Regno Unito 825
IT - Italia 554
CN - Cina 426
SE - Svezia 400
SG - Singapore 375
DE - Germania 366
VN - Vietnam 330
IN - India 162
IE - Irlanda 125
FR - Francia 108
UA - Ucraina 103
RU - Federazione Russa 96
TG - Togo 61
ZA - Sudafrica 58
EE - Estonia 54
BG - Bulgaria 39
JO - Giordania 35
CI - Costa d'Avorio 34
CH - Svizzera 29
FI - Finlandia 24
AT - Austria 23
BE - Belgio 15
GR - Grecia 14
TR - Turchia 14
ID - Indonesia 13
PL - Polonia 13
UZ - Uzbekistan 12
CA - Canada 11
ES - Italia 11
HK - Hong Kong 11
NL - Olanda 11
IR - Iran 9
CZ - Repubblica Ceca 8
NG - Nigeria 7
SC - Seychelles 7
DK - Danimarca 6
JP - Giappone 5
RO - Romania 5
AU - Australia 4
BR - Brasile 4
LB - Libano 4
MK - Macedonia 3
PT - Portogallo 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CL - Cile 2
HR - Croazia 2
KR - Corea 2
MC - Monaco 2
RS - Serbia 2
BD - Bangladesh 1
BN - Brunei Darussalam 1
IM - Isola di Man 1
MN - Mongolia 1
MX - Messico 1
PE - Perù 1
PH - Filippine 1
SA - Arabia Saudita 1
TN - Tunisia 1
Totale 8.688
Salva come PNG Salva come JPEG
Città #
Southend 732
Fairfield 518
Chandler 428
Ashburn 344
Singapore 325
Wilmington 242
Houston 240
Woodbridge 220
Seattle 212
Ann Arbor 196
Santa Clara 194
Dong Ket 175
Cambridge 170
Princeton 162
Dublin 125
Boardman 97
Bologna 90
Westminster 65
Lomé 61
Nanjing 60
Padova 59
Jacksonville 54
Turin 43
Berlin 42
Sofia 39
Jinan 36
New York 36
Amman 35
Saint Petersburg 35
Abidjan 34
San Diego 34
Milan 32
Medford 26
Redmond 24
Shenyang 24
Falls Church 23
Hebei 23
Dearborn 21
Florence 21
Redwood City 21
Beijing 20
Helsinki 20
Rome 19
Guangzhou 18
Jiaxing 18
Nanchang 18
Changsha 17
Los Angeles 15
Bern 14
Brussels 13
Des Moines 13
Tianjin 13
Norwalk 12
San Francisco 12
Vienna 12
Hangzhou 11
Hong Kong 11
Jakarta 11
Olalla 11
Bremen 10
London 10
Shanghai 10
Washington 10
Haikou 9
Paris 9
Imola 8
Istanbul 8
Mülheim 8
Phoenix 8
Zhengzhou 8
Bühl 7
Mahé 7
Pune 7
Warsaw 7
Abeokuta 6
Costa Mesa 6
Ningbo 6
Amsterdam 5
Athens 5
Braunschweig 5
Brighton 5
Brno 5
Kuban 5
San Jose 5
Shenzhen 5
Stockholm 5
Taiyuan 5
Tokyo 5
Toronto 5
Wuhan 5
Chengdu 4
Chongqing 4
Dallas 4
Foshan 4
Hefei 4
Hounslow 4
Hyderabad 4
Lanzhou 4
Lappeenranta 4
Madrid 4
Totale 5.845
Salva come PNG Salva come JPEG
Nome #
Aura uditiva in pazienti con epilessia uditiva 214
Anti-ganglioside antibodies in coeliac disease with neurological disorders. 198
Mitochondrial dysfunction in myotonic dystrophy type 1 190
Autonomic innervation in multiple system atrophy and pure autonomic failure. 178
A new case of Sando syndrome and retinitis pigmentosa with novel combination of compound heterozygous POLG mutations. 163
A 36-Year-Old Woman With Right Eye Ptosis 163
Agrypnia Excitata: a microneurographic study of muscle sympathetic nerve activity. 158
A de novo LGI1 mutation in sporadic partial epilepsy with auditory features. 153
Amyotrophic lateral sclerosis: a comparison of two staging systems in a population-based study 151
Headache in epilepsy: prevalence and clinical features 150
Autosomal dominant adult spinal muscular atrophy associated with alacrimia and achalasia. 149
Fattori prognostici in 170 pazienti con epilessia temporale mesiale 147
Broadening the Spectrum of Adulthood X-Linked Adrenoleukodystrophy: A Report of Two Atypical Cases 145
Epilepsy with auditory features: Long-term outcome and predictors of terminal remission 138
Brain & Skeletal Muscle MRS Study in Patients with Myotonic Dystrophy Type 1 136
Idebenone treatment in Leber's hereditary optic neuropathy. 134
Mesial temporal lobe epilepsy (MTLE): prognostic factors 133
Prognostic factors in patients with mesial temporal lobe epilepsy 133
Idiopathic partial epilepsy with auditory features (IPEAF): a clinical and genetic study of 53 sporadic cases. 130
Sporadic fatal insomnia in a fatal familial insomnia pedigree. 129
Skin globotriaosylceramide 3 deposits are specific to Fabry disease with classical mutations and associated with small fibre neuropathy. 129
Comparison of ice pack test and single-fiber EMG diagnostic accuracy in patients referred for myasthenic ptosis 129
Variation in Lamotrigine Plasma Concentrations with Hormonal Contraceptive Monthly Cycles in Patients with Epilepsy 128
Paraneoplastic cerebellar degeneration and lambert-eaton myasthenia in a patient with merkel cell carcinoma and voltage-gated calcium channel antibodies 128
Atypical late-onset hereditary spastic paraplegia with thin corpus callosum due to novel compound heterozygous mutations in the SPG11 gene. 125
Epilepsy with auditory features: Contribution of known genes in 112 patients 123
Relationship of white and gray matter abnormalities to clinical and genetic features in myotonic dystrophy type 1 122
Syndromic parkinsonism and dementia associated with OPA1 missense mutations 119
Kinetic-dynamic monitoring of levetiracetam effects in patients with Parkinson disease and levodopa-induced dyskinesias. 118
Development of a disability scale for myotonic dystrophy type 1. 116
Pre-symptomatic diagnosis in fatal familial insomnia: serial neurophysiological and 18FDG-PET studies 115
Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis 115
A further Rasch study confirms that ALSFRS-R does not conform to fundamental measurement requirements 114
The effect of entacapone on levodopa rate of absorption and latency to motor response in patients with Parkinson disease. 112
Riluzole and other prognostic factors in ALS: a population-based registry study in Italy 109
Fattori prognostici in 170 pazienti con epilessia temporale mesiale (ETM) 108
Sleep-related disorders and their relationship with MRI findings in multiple sclerosis 107
SPORADIC FATAL INSOMNIA IN A FATAL FAMILIAL INSOMNIA PEDIGREE 104
Sleep disorders in patients with spinal cord injury. 104
Differential cerebro spinal fluid proteome investigation of Leber hereditary optic neuropathy (LHON) and multiple sclerosis. 104
null 103
Epilepsy in MT-ATP6 - related mils/NARP: correlation of elettroclinical features with heteroplasmy 103
Non-paraneoplastic ataxia in a patient with contactin-associated protein-2 antibodies and benign course 102
Focal myoclonus and dystonia associated with celiac disease. 99
Molecular biology of channelopathies: impact on diagnosis and treatment. 99
Immunotherapy of oneiric stupor in Morvan syndrome: Efficacy documented by actigraphy 98
Epidemiology of amyotrophic lateral sclerosis in Emilia Romagna Region (Italy): A population based study. 96
Prognostic factors in patients with Mesial Temporal Lobe Epilepsy (MTLE): A preliminary study. 95
null 93
Spine Topographical Distribution of Skin α-Synuclein Deposits in Idiopathic Parkinson Disease 89
Extreme variability in genotype/phenotype correlation in an Italian family carrying the mtDNA A3243G/tRNALeu(UUR) MELAS mutation. 88
Prognostic factors in patients with mesial temporal lobe epilepsy (MTLE). 87
Subcutaneous immunoglobulin treatment and thromboembolic risk 86
Primary progressive narcolepsy type 1: the other side of the coin. 85
null 85
Small nerve fiber involvement in patients referred for fibromyalgia. 82
"Plus" features of Leber's Hereditary Optic Neuropathy in nineteen Italian families. 82
Skin nerve α-synuclein deposits: a biomarker for idiopathic Parkinson disease. 82
Effects on cognition of 20-day anodal transcranial direct current stimulation over the left dorsolateral prefrontal cortex in patients affected by mild cognitive impairment: a case-control study 81
The Impact of the COVID-19 Pandemic on People With Epilepsy. An Italian Survey and a Global Perspective 79
Low penetrance of autosomal dominant lateral temporal epilepsy in Italian families without LGI1 mutations. 76
Denervation findings on EMG in amyotrophic lateral sclerosis and correlation with prognostic milestones: Data from a retrospective study 76
Polyneuropathy in patients with mitochondrial disorders: clinical, electrophysiological and genetic evaluations. 75
High anti-streptolysin-O titres and blood-brain barrier damage in narcolepsy type 1 in the first year after symptoms onset. 74
Sensitivity and specificity of single-fibre EMG in the diagnosis of ocular myasthenia varies accordingly to clinical presentation 73
Epileptic features and deafness in a patient with 1555A>G point mutation in mitochondrial DNA. 72
Plasma and CSF Neurofilament Light Chain in Amyotrophic Lateral Sclerosis: A Cross-Sectional and Longitudinal Study 72
Early neurological manifestations of hospitalized COVID-19 patients 69
Headache and Dural Enhancement: Two Case Studies of Different Treatable Pathologies 69
Subcutaneous immunoglobulin treatment and leucopenia in acquired demyelinating peripheral neuropathies 68
Myopathy and retinopathy are novel features in a patient with Mohr-Tranebjaerg syndrome. 67
Diagnostic and Prognostic Value of Conventional Brain MRI in the Clinical Work-Up of Patients with Amyotrophic Lateral Sclerosis 67
In Vivo Parieto-Occipital White Matter Metabolism Is Correlated with Visuospatial Deficits in Adult DM1 Patients 65
Extraocular Clinical Features in Leber's Hereditary Optic Neuropathy (LHON) Italian Families. 65
Patologie dei canali ionici. 60
Targeted sequencing panels in Italian ALS patients support different etiologies in the ALS/FTD continuum 60
Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis. 58
Multiple variants in families with amyotrophic lateral sclerosis and frontotemporal dementia related to C9orf72 repeat expansion: further observations on their oligogenic nature 56
A standardized test to document cataplexy 49
Elevated plasma p-tau181 levels unrelated to Alzheimer's disease pathology in amyotrophic lateral sclerosis 48
Presence of Skin α-Synuclein Deposits Discriminates Parkinson's Disease from Progressive Supranuclear Palsy and Corticobasal Syndrome 46
Prognostic value of EMG genioglossus involvement in amyotrophic lateral sclerosis 44
Seizure worsening in pregnancy in women with sleep-related hypermotor epilepsy (SHE): A historical cohort study 42
In Vivo Diagnosis of Synucleinopathies: A Comparative Study of Skin Biopsy and RT-QuIC 40
Presynaptic paraneoplastic disorders of the neuromuscular junction: An update 37
Frequency of Parkinson’s Disease Genes and Role of PARK2 in Amyotrophic Lateral Sclerosis: An NGS Study 29
Idiopathic recurring stupor: A case with possible involvement of the gamma–aminobutyric acid (GABA)ergic system 29
Pilomotor seizures in autoimmune limbic encephalitis: description of two GAD65 antibodies- related cases and literature review 28
The Effect of Curcumin on Idiopathic Parkinson Disease: A Clinical and Skin Biopsy Study 27
Amyloid-Beta Co-Pathology Is a Major Determinant of the Elevated Plasma GFAP Values in Amyotrophic Lateral Sclerosis 25
Bibrachial amyotrophy as a rare manifestation of intraspinal fluid collection: a case report and systematic review 17
Cannabinoids for painful dystonia in corticobasal syndrome: a report of three patients 9
Totale 8.927
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.876
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.876
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.277 0 0 0 0 0 195 241 245 299 117 108 72
2020/20211.281 235 71 29 43 111 52 37 83 101 96 50 373
2021/20221.684 146 56 102 98 139 91 38 125 72 177 384 256
2022/20231.759 188 253 102 229 108 129 60 118 300 44 138 90
2023/2024576 49 92 38 67 49 117 34 38 17 29 20 26
2024/20251.036 92 330 170 124 316 4 0 0 0 0 0 0
Totale 8.927